<ul>
<li>Orchestra BioMed director Aryeh Jason bought 665 shares of common stock at a weighted average price of $3.75.     *      Direct holdings rose to 118,118 shares following the purchase. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orchestra Biomed Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-064136), on May 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here</li>
</ul>

OBIO

LABU

SBIO

<p>Orchestra BioMed director Aryeh Jason purchased 665 shares of common stock at an average price of $3.75, increasing his total holdings to 118,118 shares. The total investment amounted to $2,493.75.</p>

PUBT

Orchestra BioMed

SPDR S&P Biotech

Proshares Ultra Nasdaq Biotech

VanEck Biotech ETF

Direxion S&P Biotech Bull 3X

iShares Biotechnology ETF

Invesco Biotechnology & Genome ETF

ALPS Medical Breakthrough

First Trust NYSE Arca Biotech Index Fd

Orchestra BioMed director Aryeh Jason buys 665 shares worth $2,493.75